| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $38.4M | -3.3% | -3.8% |
| Cost of Revenue | $22.5M | -10.1% | -24.8% |
| Gross Profit | $15.9M | +8.3% | +58.9% |
| R&D Expense | $22.8M | +1.4% | -10.5% |
| SG&A Expense | $31.1M | -14.0% | -28.9% |
| Operating Income | -$38.9M | +13.3% | +39.3% |
| Pre-tax Income | -$37.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.5M | +3.0% | -27.6% |
| Short-term Investments | $242.2M | -6.8% | -38.4% |
| Accounts Receivable | $30.6M | -5.1% | +4.2% |
| Inventory | $53.2M | -1.3% | -19.1% |
| Current Assets | $394.2M | -4.6% | -32.5% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$92.1M | — | — |
| Capital Expenditures | $1.9M | — | — |
| Investing Cash Flow | $89.4M | — | — |
| Financing Cash Flow | $3.4M | — | — |
| Free Cash Flow | -$94.0M | — | — |
| +10.2% |
| +38.1% |
| Income Tax | $383K | +994.3% | — |
| Net Income | -$38.0M | +9.4% | +37.4% |
| EPS (Basic) | -$0.13 | +7.1% | +40.9% |
| EPS (Diluted) | -$0.13 | +7.1% | +40.9% |
| $803.2M |
| -2.7% |
| -44.6% |
| Current Liabilities | $63.2M | +5.8% | +5.4% |
| Total Liabilities | $767.1M | +0.4% | -23.1% |
| Stockholders' Equity | $36.1M | -41.3% | -92.0% |